ORIC Pharmaceuticals, Inc.
ORIC
$13.87
$0.151.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -140.35M | -135.21M | -129.47M | -135.27M | -137.25M |
| Total Depreciation and Amortization | 1.14M | 1.19M | 1.22M | 1.20M | 1.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.52M | 24.13M | 22.74M | 20.27M | 18.33M |
| Change in Net Operating Assets | 2.05M | -974.00K | -5.46M | -2.74M | -2.50M |
| Cash from Operations | -111.64M | -110.88M | -110.97M | -116.54M | -120.23M |
| Capital Expenditure | -620.00K | -327.00K | -712.00K | -704.00K | -1.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.04M | -188.13M | -147.32M | -121.66M | 12.33M |
| Cash from Investing | -99.66M | -188.46M | -148.03M | -122.36M | 11.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 175.65M | 309.54M | 247.66M | 246.74M | 135.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.73M | -3.15M | -2.40M | -2.40M | -656.00K |
| Cash from Financing | 172.92M | 306.39M | 245.26M | 244.34M | 135.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.38M | 7.06M | -13.74M | 5.44M | 26.03M |